Auf dieser Seite
ICUI ICU Medical, Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 6, 2026
$159,38
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$112,5052-Wochen-Tief
$192,8552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.99B
P/E (TTM)
133.9
EPS (TTM)
$1.19
Umsatz (TTM)
$2.16B
Ihre Abzeichen
52W-Spanne
$112–$193
Analystenbewertung
BUY
Kursziel
$193
P/E
133.9
ROE
1.4%
Nettogewinnmarge
1.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
ICUI Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$159.38
Marktkapitalisierung (MRQ)
$3.99B
P/E (TTM)
133.9
EPS (TTM)
$1.19
Umsatz (TTM)
$2.16B
ROE (TTM)
1.4%
Verschuldungsgrad (MRQ)
0.6
52W-Spanne
$113–$193
ICUI Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 18. März 2002 | 3-for-2 | Vorwärts |
| 1. April 1993 | 3-for-2 | Vorwärts |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2.23B2016-12-31 → 2025-12-31
EPS$0.032016-12-31 → 2025-12-31
Freier Cashflow$92M2016-12-31 → 2025-12-31
Nettogewinnmarge1.4%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | ICUI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 133.95-Jahres-Durchschnitt ≈928.4 | ≈928.4 | 28.6 | Überbewertet | |
| P/S (TTM) | 1.85-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 2.6 | Unterbewertet | |
| K/B (MRQ) | 1.95-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 2.5 | Unterbewertet | |
| Kurs / FCF (TTM) | 26.15-Jahres-Durchschnitt ≈30.9 | ≈30.9 | · | · | |
| Kurs / Cashflow (TTM) | 16.95-Jahres-Durchschnitt ≈17.9 | ≈17.9 | 17.6 | Überbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 2.5 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | ICUI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 39.1%5-Jahres-Durchschnitt ≈34.4% | ≈34.4% | 55.0% | Schwach | |
| Betriebsgewinnmarge (TTM) | 3.3%5-Jahres-Durchschnitt ≈2.4% | ≈2.4% | 11.6% | Schwach | |
| EBITDA-Marge (TTM) | 12.7%5-Jahres-Durchschnitt ≈11.5% | ≈11.5% | 14.3% | Schwach | |
| Vorgewinnmarge (TTM) | 0.03% | · | 10.9% | Schwach | |
| Nettogewinnmarge (TTM) | 1.4%5-Jahres-Durchschnitt ≈-0.33% | ≈-0.33% | 8.9% | Schwach | |
| ROA (TTM) | 0.74%5-Jahres-Durchschnitt ≈-0.01% | ≈-0.01% | 1.6% | Unterdurchschnittlich | |
| ROE (TTM) | 1.4%5-Jahres-Durchschnitt ≈-0.87% | ≈-0.87% | 4.2% | Unterdurchschnittlich | |
| ROIC | 0.55% | · | 3.2% | Unterdurchschnittlich |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | ICUI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.65-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.5 | Im Einklang | |
| Liquiditätsgrad (MRQ) | 2.45-Jahres-Durchschnitt ≈3.0 | ≈3.0 | 3.0 | Geringe Liquidität | |
| Quick Ratio | 0.45-Jahres-Durchschnitt ≈1.3 | ≈1.3 | 1.6 | Geringe Liquidität | |
| Langfristige Schulden / Eigenkapital (MRQ) | 0.65-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.6 | Im Einklang | |
| Interest Coverage (Zinsdeckungsgrad) | 0.55-Jahres-Durchschnitt ≈28.8 | ≈28.8 | 4.2 | Unterdurchschnittlich |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | ICUI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -6.3%5-Jahres-Durchschnitt ≈15.0% | ≈15.0% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -0.72%5-Jahres-Durchschnitt ≈14.1% | ≈14.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 11.9% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -62.5% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -61.5% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | ICUI | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.6 | ≈0.6 | 0.6 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 2.35-Jahres-Durchschnitt ≈2.6 | ≈2.6 | 2.8 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 12.35-Jahres-Durchschnitt ≈12.7 | ≈12.7 | 6.4 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$171.6K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
25.0%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 10, 2026 | $2.37 | $1.95 | 21.4% |
| 31. März 2026 | $1.97 | $1.79 | 10.3% | |
| 31. Dezember 2025 | $1.91 | $1.73 | 10.7% | |
| 30. September 2025 | $2.03 | $1.46 | 38.9% | |
| 30. Juni 2025 | $2.10 | $1.53 | 37.3% | |
| 31. März 2025 | $1.72 | $1.31 | 31.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379M | $342M | $309M | |
| Cost of Revenue | $1.41B | $1.56B | $1.52B | $1.58B | $825M | $810M | $794M | $830M | $867M | $178M | $161M | $158M | |
| Gross Profit | $822M | $825M | $740M | $698M | $491M | $461M | $472M | $570M | $426M | $201M | $181M | $151M | |
| R&D Expense | $87M | $89M | $85M | $93M | $47M | $43M | $49M | $53M | $51M | $13M | $16M | $18M | |
| SG&A Expense | $625M | $639M | $607M | $608M | $303M | $284M | $277M | $320M | $302M | $89M | $83M | $89M | |
| Operating Expenses | $779M | $782M | $717M | $741M | $368M | $363M | $365M | $540M | $439M | $118M | $112M | $112M | |
| Operating Income | $43M | $43M | $23M | $-43M | $123M | $98M | $107M | $30M | $-13M | $83M | $69M | $39M | |
| Interest Expense | $93M | $107M | $103M | $71M | $858.0K | $2M | $549.0K | $709.0K | $2M | $118.0K | $39.0K | · | |
| Other Non-op | $-232.0K | $-13M | $-6M | $-5M | $-2M | $-3M | $8M | $-7M | $-4M | $885.0K | $1M | $755.0K | |
| Pretax Income | $4M | $-66M | $-78M | · | · | $97M | $115M | $22M | $51M | $85M | $70M | $40M | |
| Income Tax | $2M | $52M | $-49M | $-40M | $20M | $11M | $14M | $-6M | $-17M | $22M | $25M | $13M | |
| Net Income | $732.0K | $-118M | $-30M | $-74M | $103M | $87M | $101M | $29M | $69M | $63M | $45M | $26M | |
| EPS (Basic) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.86 | $4.16 | $4.90 | $1.41 | $3.50 | $3.90 | $2.84 | $1.72 | |
| EPS (Diluted) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 | |
| Shares (Basic) | 24,640,000 | 24,388,000 | 24,091,000 | 23,868,000 | 21,206,000 | 20,907,000 | 20,629,000 | 20,394,000 | 19,614,000 | 16,168,000 | 15,848,000 | 15,282,000 | |
| Shares (Diluted) | 24,904,000 | 24,388,000 | 24,091,000 | 23,868,000 | 21,781,000 | 21,591,000 | 21,545,000 | 21,601,000 | 20,858,000 | 17,254,000 | 16,496,000 | 15,647,000 | |
| EBITDA | $244M | $262M | $252M | $192M | $213M | $184M | $184M | $96M | $51M | $102M | $87M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $309M | $255M | $213M | $553M | $396M | $269M | $345M | $290M | $445M | $336M | $276M | |
| Short-term Investments | · | · | · | · | · | $15M | $24M | $37M | $10M | $0 | $41M | $71M | |
| Receivables | $181M | $183M | $162M | $222M | $106M | $124M | $202M | $176M | $113M | $56M | $58M | $39M | |
| Inventory | $616M | $585M | $709M | $696M | $290M | $315M | $338M | $311M | $289M | $49M | $44M | $37M | |
| Prepaid Expense | $86M | $82M | $74M | $89M | $47M | $41M | $34M | $46M | $41M | $7M | $8M | $6M | |
| Other Current Assets | $26M | $23M | $4M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | · | · | |
| Current Assets | $1.19B | $1.44B | $1.22B | $1.24B | $1.03B | $921M | $882M | $927M | $865M | $569M | $505M | $433M | |
| PP&E (Net) | $452M | $443M | $613M | $636M | $468M | $467M | $456M | $433M | $399M | $86M | $74M | $86M | |
| PP&E (Gross) | $1.10B | $1.04B | $1.24B | $1.16B | $905M | $843M | $776M | $695M | $609M | $244M | $223M | $225M | |
| Accum. Depreciation | $646M | $593M | $624M | $526M | $437M | $376M | $320M | $262M | $210M | $158M | $149M | $139M | |
| Goodwill | $1.50B | $1.43B | $1.47B | $1.45B | $43M | $33M | $31M | $11M | $12M | $6M | $6M | $1M | |
| Intangibles | $634M | $741M | $871M | $983M | $188M | $197M | $211M | $133M | $144M | $22M | $24M | $7M | |
| Other Non-current Assets | $63M | $65M | $94M | $105M | $64M | $55M | $49M | $40M | $38M | $0 | · | · | |
| Total Assets | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $705M | $627M | $541M | |
| Accounts Payable | $154M | $148M | $150M | $216M | $81M | $72M | $129M | $120M | $78M | $15M | $14M | $11M | |
| Accrued Liabilities | $315M | $307M | $268M | $243M | $118M | $97M | $118M | $129M | $132M | $26M | $29M | $17M | |
| Current Liabilities | $499M | $556M | $482M | $495M | $201M | $195M | $248M | $249M | $210M | $41M | $43M | $29M | |
| Capital Leases | $44M | $41M | $53M | $61M | $34M | $41M | $29M | $0 | $0 | · | · | · | |
| Deferred Tax | $38M | $49M | $56M | $126M | $1M | $2M | $2M | $721.0K | $1M | $1M | $1M | $1M | |
| Other Non-current Liabilities | $90M | $67M | $100M | $114M | $42M | $48M | $33M | · | · | · | · | · | |
| Long-term Debt | $1.28B | $1.58B | $1.63B | $1.65B | $0 | · | · | · | · | · | · | · | |
| Total Debt | $1.28B | $1.58B | $1.63B | $1.65B | · | · | · | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Retained Earnings | $691M | $690M | $808M | $838M | $912M | $809M | $722M | $621M | $586M | $517M | $454M | $409M | |
| Treasury Stock | $22.0K | $92.0K | $262.0K | $243.0K | $27.0K | $39.0K | $157.0K | $95.0K | $0 | $14.0K | $0 | $0 | |
| AOCI | $-35M | $-139M | $-53M | $-81M | $-19M | $-2M | $-15M | $-17M | $-15M | $-21M | $-21M | $-10M | |
| Stockholders' Equity | $2.12B | $1.97B | $2.12B | $2.09B | $1.62B | $1.50B | $1.38B | $1.26B | $1.20B | $660M | $580M | $508M | |
| Liabilities + Equity | $4.05B | $4.20B | $4.38B | $4.52B | $1.88B | $1.76B | $1.69B | $1.59B | $1.50B | $705M | $627M | $541M | |
| Shares Outstanding | 24,688,000 | 24,517,000 | 24,141,000 | 23,993,000 | 21,280,000 | 21,058,000 | 20,742,000 | 20,491,229 | 20,210,054 | 16,337,670 | 16,086,000 | 15,595,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $201M | $220M | $229M | $235M | $90M | $86M | $77M | $75M | $67M | $19M | $18M | $19M | |
| Stock-based Comp | $56M | $47M | $41M | $36M | $27M | $24M | $22M | $24M | $19M | $15M | $13M | $10M | |
| Deferred Tax | $-14M | $6M | $-70M | $-61M | $-11M | $-5M | $-4M | $-18M | $-26M | $-3M | $4M | $-1M | |
| Amort. of Intangibles | $131M | $134M | $132M | $139M | $24M | $23M | $18M | $17M | $15M | $3M | $2M | $2M | |
| Restructuring | · | · | $6M | $10M | $-2M | $8M | $8M | $4M | $19M | $800.0K | $7M | $4M | |
| Other Non-cash | $-64M | $50M | $-2M | $-198M | $59M | $31M | $-94M | $50M | $25M | $-5M | $-25M | · | |
| Operating Cash Flow | $180M | $204M | $166M | $-62M | $268M | $223M | $102M | $160M | $154M | $90M | $64M | $66M | |
| CapEx | $88M | $79M | $84M | $90M | $69M | $92M | $97M | $93M | $74M | $23M | $13M | $17M | |
| Investing Cash Flow | $122M | $-89M | $-88M | $-1.91B | $-91M | $-98M | $-167M | $-103M | $-267M | $16M | $-11M | $-22M | |
| Net Debt Issued | $-303M | $-51M | $-30M | $-22M | $0 | $-150M | $0 | $0 | $-75M | · | · | · | |
| Stock Repurchased | $9M | $12M | $9M | $11M | $8M | $13M | $19M | $6M | $4M | $17M | $2M | $6M | |
| Net Stock Activity | $-9M | $-12M | $-9M | $-11M | $-8M | $-13M | $-19M | $-6M | $-4M | $-17M | $-2M | · | |
| Financing Cash Flow | $-312M | $-56M | $-36M | $1.64B | $-17M | $-40.0K | $-11M | $8M | $-44M | $2M | $16M | $14M | |
| Net Change in Cash | $-603.0K | $54M | $45M | $-344M | $157M | $127M | $-76M | $55M | $-155M | $109M | $60M | $50M | |
| Free Cash Flow | $92M | $125M | $82M | $-152M | $199M | $131M | $5M | $67M | $80M | $67M | $42M | · | |
| Levered FCF | $51M | · | · | · | · | $129M | $4M | $67M | $77M | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% | 36.3% | 37.3% | 40.7% | 33.0% | 53.1% | 52.9% | · | |
| Operating Margin | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% | 7.7% | 8.5% | 1.5% | -1.2% | 21.9% | 20.1% | · | |
| Net Margin | 0.03% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% | 13.2% | · | |
| Pretax Margin | 0.20% | · | · | · | · | 7.7% | 9.1% | 1.6% | 4.0% | 22.4% | 20.4% | · | |
| EBITDA Margin | 10.9% | 11.0% | 11.1% | 8.4% | 16.2% | 14.5% | 14.5% | 6.9% | 4.0% | 26.9% | 25.4% | · | |
| ROA | 0.02% | -2.7% | -0.67% | -2.3% | 5.7% | 5.0% | 6.2% | 1.9% | 6.2% | 9.5% | 7.7% | · | |
| ROE | 0.03% | -5.9% | -1.4% | -3.5% | 6.4% | 5.9% | 7.4% | 2.3% | 7.4% | 10.2% | 8.3% | · | |
| ROIC | 0.55% | · | · | · | · | 5.8% | 6.9% | 2.2% | -1.7% | 9.3% | 7.6% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.6 | 2.5 | 2.5 | 5.1 | 4.7 | 3.6 | 3.7 | 4.1 | 14.0 | 11.8 | · | |
| Quick Ratio | 0.4 | 0.9 | 0.9 | 0.9 | 3.3 | 2.7 | 2.0 | 2.2 | 2.0 | 12.4 | 10.2 | · | |
| Debt / Equity | 0.6 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.6 | 0.8 | 0.7 | 0.8 | · | · | · | · | · | · | · | · | |
| Interest Coverage | 0.5 | 0.4 | 0.2 | -0.6 | 143.6 | 56.0 | 195.6 | 30.5 | -7.4 | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.5 | 0.7 | 0.7 | 0.7 | 0.8 | 0.9 | 1.2 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.3 | 2.4 | 2.2 | 3.2 | 2.7 | 2.5 | 2.4 | 2.8 | 3.0 | 3.8 | 4.0 | · | |
| Receivables Turnover | 12.3 | 13.8 | 11.8 | 13.9 | 11.4 | 7.8 | 6.7 | 9.7 | 15.3 | 6.7 | 7.1 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $86.03 | $80.16 | $87.96 | · | $75.94 | $71.34 | $66.40 | $61.67 | $59.29 | $40.41 | $36.05 | · | |
| Revenue / Share | $89.59 | $97.67 | $93.77 | $95.53 | $60.43 | $58.87 | $58.77 | $64.81 | $61.97 | $21.99 | $20.71 | · | |
| Cash Flow / Share | $7.22 | $8.37 | $6.90 | $-2.60 | $12.28 | $10.32 | $4.73 | $7.42 | $7.40 | $5.21 | $3.33 | · | |
| Cash / Share | · | $12.59 | $10.55 | · | $25.98 | $18.81 | $12.95 | $16.83 | $14.35 | $27.24 | $20.90 | · | |
| EPS (TTM) | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 | $2.73 | $1.68 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -6.3% | 5.4% | -0.92% | 73.2% | 3.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -0.72% | 21.9% | 21.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 17.9% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -62.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 18.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -61.5% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B | $1.27B | $1.27B | $1.40B | $1.29B | $379M | $342M | $309M | |
| Net Income TTM | $732.0K | $-118M | $-30M | $-74M | $103M | $87M | $101M | $29M | $69M | $63M | $45M | $26M | |
| Market Cap | $3.52B | $3.80B | $2.41B | · | $5.05B | $4.52B | $3.88B | $4.71B | $4.37B | $2.41B | $1.81B | · | |
| Enterprise Value | · | $5.08B | $3.78B | · | · | · | · | · | · | · | · | · | |
| P/E | 4755.7 | -32.1 | -81.1 | -50.6 | 50.1 | 53.4 | 39.9 | 172.7 | 65.7 | 40.3 | 41.3 | 48.8 | |
| P/S | 1.6 | 1.6 | 1.1 | · | 3.8 | 3.6 | 3.1 | 3.4 | 3.4 | 6.3 | 5.3 | · | |
| P/B | 1.7 | 1.9 | 1.1 | · | 3.1 | 3.0 | 2.8 | 3.7 | 3.6 | 3.6 | 3.1 | · | |
| P / Tangible Book | · | · | · | · | 3.6 | 3.6 | · | · | · | · | · | · | |
| P / Cash Flow | 19.6 | 18.6 | 14.5 | · | 18.9 | 20.3 | 38.1 | 29.4 | 28.3 | 26.8 | 33.1 | · | |
| P / FCF | 38.4 | 30.5 | 29.3 | · | 25.4 | 34.5 | 842.7 | 69.7 | 54.6 | 36.2 | 43.3 | · | |
| EV / EBITDA | · | 19.3 | 15.0 | · | · | · | · | · | · | · | · | · | |
| EV / FCF | · | 40.7 | 45.9 | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 2.1 | 1.7 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | 0.02% | -3.1% | -1.2% | -2.0% | 2.0% | 1.9% | 2.5% | 0.58% | 1.5% | 2.5% | 2.4% | 2.1% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $552M | $530M | $541M | $537M | $549M | $605M | $630M | $589M | $596M | $567M | $588M | $553M | $549M | $569M | $578M | $598M | |
| Cost of Revenue | $317M | $324M | $338M | $336M | $341M | $395M | $403M | $384M | $389M | $381M | $416M | $369M | $357M | $377M | $403M | $411M | |
| Gross Profit | $235M | $206M | $203M | $201M | $208M | $210M | $227M | $205M | $207M | $185M | $172M | $184M | $192M | $192M | $175M | $186M | |
| R&D Expense | $23M | $21M | $21M | $21M | $22M | $23M | $22M | $21M | $23M | $22M | $22M | $21M | $22M | $20M | $23M | $23M | |
| SG&A Expense | $152M | $155M | $156M | $153M | $159M | $157M | $159M | $163M | $160M | $158M | $155M | $149M | $151M | $153M | $143M | $153M | |
| Operating Expenses | $196M | $193M | $197M | $187M | $197M | $197M | $190M | $197M | $200M | $196M | $184M | $161M | $190M | $183M | $175M | $187M | |
| Operating Income | $39M | $14M | $6M | $14M | $11M | $13M | $38M | $8M | $8M | $-11M | $-12M | $23M | $3M | $9M | $-222.0K | $-467.0K | |
| Interest Expense | $16M | $16M | $31M | $20M | $21M | $22M | $34M | $25M | $24M | $24M | $32M | $24M | $24M | $23M | $25M | $18M | |
| Other Non-op | $-236.0K | $-1M | $-894.0K | $607.0K | $2M | $-2M | $-6M | $-1M | $-3M | $-2M | $-90.0K | $-4M | $-2M | $-269.0K | $-1M | $-3M | |
| Pretax Income | $23M | $-4M | $-16M | $-3M | $34M | $-11M | $8M | $-18M | $-20M | $-37M | $-37M | $-5M | $-23M | $-13M | · | $-21M | |
| Income Tax | $7M | $-35M | $-3M | $-658.0K | $1M | $5M | $32M | $15M | $2M | $3M | $-20M | $-13M | $-13M | $-4M | $-6M | $-8M | |
| Net Income | $19M | $30M | $-16M | $-3M | $35M | $-15M | $-24M | $-33M | $-21M | $-39M | $-17M | $7M | $-10M | $-10M | $-19M | $-10M | |
| EPS (Basic) | $0.76 | $1.22 | $-0.63 | $-0.14 | $1.43 | $-0.63 | $-0.97 | $-1.35 | $-0.88 | $-1.63 | $-0.71 | $0.30 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | |
| EPS (Diluted) | $0.76 | $1.20 | $-0.63 | $-0.14 | $1.43 | $-0.63 | $-0.97 | $-1.35 | $-0.88 | $-1.63 | $-0.71 | $0.30 | $-0.41 | $-0.41 | $-0.64 | $-0.55 | |
| Shares (Basic) | 25,000,000 | 24,764,000 | · | 24,686,000 | 24,645,000 | 24,539,000 | · | 24,438,000 | 24,393,000 | 24,222,000 | · | 24,132,000 | 24,075,000 | 24,014,000 | · | 23,908,000 | |
| Shares (Diluted) | 25,044,000 | 25,182,000 | · | 24,686,000 | 24,708,000 | 24,539,000 | · | 24,438,000 | 24,393,000 | 24,222,000 | · | 24,368,000 | 24,075,000 | 24,014,000 | · | 23,908,000 | |
| EBITDA | $39M | $64M | · | $14M | $11M | $62M | · | $8M | $8M | $45M | · | $23M | $3M | $65M | · | $-467.0K |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $313M | $303M | $251M | · | $199M | $198M | $224M | · | $247M | |
| Receivables | $184M | $201M | $181M | $192M | $179M | $171M | $183M | $174M | $152M | $145M | · | $162M | $162M | $139M | · | $213M | |
| Inventory | $607M | $606M | $616M | $622M | $616M | $590M | $585M | $692M | $683M | $693M | · | $760M | $775M | $748M | · | $625M | |
| Prepaid Expense | $122M | $118M | $86M | $94M | $84M | $75M | $82M | $74M | $81M | $83M | · | $84M | $96M | $87M | · | $94M | |
| Other Current Assets | $34M | $39M | $20M | $23M | $23M | $6M | $23M | $5M | $5M | $4M | · | $3M | $3M | $4M | · | $3M | |
| Current Assets | $1.21B | $1.21B | $1.19B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B | $1.24B | $1.19B | · | $1.22B | $1.24B | $1.21B | · | $1.20B | |
| PP&E (Net) | $447M | $445M | $452M | $456M | $452M | $442M | $443M | $596M | $594M | $603M | · | $609M | $617M | $624M | · | $656M | |
| PP&E (Gross) | $1.12B | $1.11B | $1.10B | $1.09B | $1.08B | $1.05B | $1.04B | $1.28B | $1.26B | $1.25B | · | $1.21B | $1.19B | $1.17B | · | $1.15B | |
| Accum. Depreciation | $676M | $661M | $646M | $636M | $630M | $608M | $593M | $685M | $664M | $644M | · | $597M | $575M | $550M | · | $498M | |
| Goodwill | $1.48B | $1.49B | $1.50B | $1.50B | $1.50B | $1.46B | $1.43B | $1.48B | $1.45B | $1.46B | $1.47B | $1.44B | $1.46B | $1.46B | $1.45B | $1.37B | |
| Intangibles | $568M | $599M | $634M | $665M | $698M | $717M | $741M | $786M | $806M | $837M | · | $891M | $930M | $958M | · | $1.02B | |
| Other Non-current Assets | $63M | $63M | $63M | $61M | $61M | $65M | $65M | $87M | $95M | $97M | · | $108M | $100M | $102M | · | $111M | |
| Total Assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | · | $4.38B | $4.46B | $4.47B | · | $4.45B | |
| Accounts Payable | $149M | $174M | $154M | $172M | $169M | $180M | $148M | $169M | $156M | $152M | · | $149M | $167M | $186M | · | $205M | |
| Accrued Liabilities | $322M | $315M | $315M | $316M | $314M | $279M | $307M | $326M | $300M | $248M | · | $251M | $255M | $235M | · | $244M | |
| Current Liabilities | $498M | $518M | $499M | $493M | $483M | $549M | $556M | $550M | $512M | $455M | · | $464M | $484M | $462M | · | $489M | |
| Capital Leases | $37M | $41M | $44M | $47M | $49M | $48M | $41M | $45M | $52M | $50M | · | $57M | $60M | $63M | · | $63M | |
| Deferred Tax | $12M | $15M | $38M | $41M | $43M | $45M | $49M | $49M | $54M | $56M | · | $78M | $90M | $115M | · | $154M | |
| Other Non-current Liabilities | $71M | $82M | · | $94M | $96M | $78M | · | $80M | $91M | $103M | · | $100M | $110M | $114M | · | $119M | |
| Long-term Debt | $1.23B | $1.28B | $1.28B | $1.31B | $1.34B | $1.54B | $1.58B | $1.59B | $1.61B | $1.62B | · | $1.63B | $1.64B | $1.65B | · | $1.65B | |
| Total Debt | $1.23B | $1.28B | · | $1.31B | $1.34B | $1.54B | · | $1.59B | $1.61B | $1.62B | · | $1.63B | $1.64B | $1.65B | · | $1.65B | |
| Common Stock | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Retained Earnings | $740M | $721M | $691M | $707M | $710M | $675M | $690M | $714M | $747M | $768M | · | $825M | $818M | $828M | · | $853M | |
| Treasury Stock | $23M | $25M | $22.0K | $12.0K | $6.0K | $60.0K | $92.0K | $208.0K | $518.0K | $5M | · | $672.0K | $2M | $8M | · | $126.0K | |
| AOCI | $-43M | $-52M | $-35M | $-33M | $-33M | $-105M | $-139M | $-62M | $-92M | $-70M | $-53M | $-85M | $-49M | $-62M | $-81M | $-166M | |
| Stockholders' Equity | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B | $2.04B | · | $2.12B | $2.10B | $2.11B | $2.10B | $2.09B | $2.01B | |
| Liabilities + Equity | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B | · | $4.38B | $4.46B | $4.47B | · | $4.45B | |
| Shares Outstanding | 25,007,000 | 24,993,000 | 24,688,000 | 24,686,000 | 24,685,000 | 24,611,000 | 24,517,000 | 24,459,000 | 24,425,000 | 24,365,000 | · | 24,139,000 | 24,104,000 | 24,064,000 | · | 23,979,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $50M | $50M | $51M | $51M | $50M | $49M | $53M | $56M | $55M | $56M | $57M | $58M | $58M | $56M | $57M | $59M | |
| Stock-based Comp | $12M | $14M | $14M | $15M | $14M | $12M | $13M | $12M | $11M | $12M | $11M | $11M | $10M | $9M | $7M | $9M | |
| Amort. of Intangibles | $33M | $33M | $33M | $33M | $33M | $33M | $34M | $34M | $33M | $33M | $33M | $33M | $33M | $32M | $30M | $36M | |
| Restructuring | $7M | $7M | · | $6M | $8M | $7M | · | $4M | $8M | $5M | · | $1M | $1M | $3M | · | $2M | |
| Other Non-cash | · | $-55M | · | · | · | $5M | · | · | · | · | · | · | · | $-14M | · | · | |
| Operating Cash Flow | $80M | $39M | $61M | $57M | $11M | $51M | $40M | $36M | $82M | $46M | $91M | $35M | $-1M | $41M | $-2M | $2M | |
| CapEx | $19M | $11M | $25M | $29M | $20M | $15M | $24M | $20M | $19M | $16M | $30M | $21M | $18M | $14M | $22M | $21M | |
| Investing Cash Flow | $-20M | $-11M | $-18M | $-30M | $187M | $-17M | $-27M | $-23M | $-22M | $-18M | $-31M | $-25M | $-18M | $-15M | $-24M | $-13M | |
| Net Debt Issued | · | $-5M | · | · | · | $-48M | · | · | · | $-13M | · | · | · | $-7M | · | · | |
| Financing Cash Flow | $-50M | $-44M | $-34M | $-26M | $-195M | $-56M | $-8M | $-10M | $-10M | $-27M | $-8M | $-6M | $-6M | $-16M | $-10M | $3M | |
| Net Change in Cash | $10M | $-20M | $8M | $-293.0K | $10M | $-19M | $-4M | $10M | $51M | $-3M | $57M | $1M | $-25M | $12M | $-35M | $-12M | |
| Free Cash Flow | · | $28M | · | · | · | $37M | · | · | · | $30M | · | · | · | $27M | · | · | |
| Levered FCF | · | $155M | · | · | · | $5M | · | · | · | $4M | · | · | · | $11M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.6% | 38.9% | · | 37.4% | 37.9% | 34.8% | · | 34.8% | 34.8% | 32.7% | · | 33.2% | 35.0% | 33.8% | · | 31.2% | |
| Operating Margin | 7.1% | 2.6% | · | 2.5% | 1.9% | 2.1% | · | 1.4% | 1.3% | -1.9% | · | 4.1% | 0.50% | 1.7% | · | -0.08% | |
| Net Margin | 3.5% | 5.7% | · | -0.63% | 6.4% | -2.6% | · | -5.6% | -3.6% | · | · | 1.3% | -1.8% | -1.7% | · | -2.2% | |
| Pretax Margin | 4.2% | -0.75% | · | -0.47% | 6.1% | -1.8% | · | -3.0% | -3.3% | -6.5% | · | -0.97% | -4.2% | -2.4% | · | -3.6% | |
| EBITDA Margin | 7.1% | 12.0% | · | 2.5% | 1.9% | 10.3% | · | 1.4% | 1.3% | 7.9% | · | 4.1% | 0.50% | 11.5% | · | -0.08% | |
| ROA | 0.47% | 0.74% | · | -0.08% | 0.84% | -0.37% | · | -0.76% | -0.49% | · | · | 0.16% | -0.22% | -0.21% | · | -0.42% | |
| ROE | 0.89% | 1.5% | · | -0.16% | 1.7% | -0.76% | · | -1.6% | -1.0% | · | · | 0.35% | -0.47% | -0.46% | · | -0.73% | |
| ROIC | 0.80% | -3.1% | · | 0.29% | 0.30% | 0.52% | · | 0.42% | 0.23% | -0.71% | · | -0.83% | 0.03% | 0.18% | · | -0.01% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 2.3 | · | 2.4 | 2.4 | 2.6 | · | 2.3 | 2.4 | 2.6 | · | 2.6 | 2.6 | 2.6 | · | 2.5 | |
| Quick Ratio | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.7 | 0.8 | · | 0.9 | |
| Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.8 | · | 0.8 | 0.8 | · | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| LT Debt / Equity | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.8 | 0.8 | · | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Interest Coverage | 2.5 | 0.8 | · | 0.7 | 0.5 | 0.6 | · | 0.3 | 0.3 | -0.4 | · | 0.9 | 0.1 | 0.4 | · | -0.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.9 | |
| Receivables Turnover | 3.0 | 2.9 | · | 2.9 | 3.3 | 3.8 | · | 3.5 | 3.8 | 4.0 | · | 3.0 | 2.9 | 3.3 | · | 3.6 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $86.05 | $84.50 | · | $86.17 | $85.71 | $80.76 | · | $83.76 | $83.43 | · | · | $86.93 | $87.74 | $87.28 | · | $83.94 | |
| Revenue / Share | $22.03 | $21.06 | · | $21.75 | $22.21 | $24.64 | · | $24.11 | $24.45 | $23.39 | · | $22.71 | $22.82 | $23.68 | · | $25.01 | |
| Cash Flow / Share | · | $1.55 | · | · | · | $2.09 | · | · | · | $1.89 | · | · | · | $1.72 | · | · | |
| Cash / Share | · | · | · | · | · | · | · | $12.78 | $12.39 | $10.32 | · | $8.24 | $8.20 | $9.32 | · | $10.29 | |
| EPS (TTM) | $1.19 | $1.86 | · | $-0.31 | $-1.52 | $-3.83 | · | $-4.57 | $-2.92 | $-2.45 | · | $-1.16 | $-2.01 | $-1.91 | · | $-1.56 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.16B | $2.16B | · | $2.32B | $2.37B | $2.42B | · | $2.34B | $2.30B | $2.26B | · | $2.25B | $2.29B | $2.31B | · | $2.04B | |
| Net Income TTM | $30M | $46M | · | $-7M | $-37M | $-94M | · | $-111M | $-71M | $-59M | · | $-31M | $-48M | $-46M | · | $-35M | |
| Market Cap | $3.67B | $3.23B | · | $2.96B | $3.26B | $3.42B | · | $4.46B | $2.90B | $2.61B | · | $2.87B | $4.30B | $3.97B | · | $3.61B | |
| Enterprise Value | · | · | · | · | · | · | · | $5.74B | $4.20B | $3.98B | · | $4.31B | $5.74B | $5.39B | · | $5.02B | |
| P/E | 123.2 | 69.4 | · | -387.0 | -86.9 | -36.3 | · | -39.9 | -40.7 | -43.8 | · | -102.6 | -88.7 | -86.4 | · | -96.5 | |
| P/S | 1.7 | 1.5 | · | 1.3 | 1.4 | 1.4 | · | 1.9 | 1.3 | 1.2 | · | 1.3 | 1.9 | 1.7 | · | 1.8 | |
| P/B | 1.7 | 1.5 | · | 1.4 | 1.5 | 1.7 | · | 2.2 | 1.4 | · | · | 1.4 | 2.0 | 1.9 | · | 1.8 | |
| P / Tangible Book | 36.7 | 117.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 83.0 | · | · | · | 66.6 | · | · | · | 57.1 | · | · | · | 96.2 | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | 2.5 | 1.8 | 1.8 | · | 1.9 | 2.5 | 2.3 | · | 2.5 | |
| Earnings Yield | 0.81% | 1.4% | · | -0.26% | -1.1% | -2.8% | · | -2.5% | -2.5% | -2.3% | · | -0.97% | -1.1% | -1.2% | · | -1.0% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2.23B | $2.38B | $2.26B | $2.28B | $1.32B |
| Bruttogewinnmarge % | 36.8% | 34.6% | 32.8% | 30.6% | 37.3% |
| Betriebsgewinnmarge % | 1.9% | 1.8% | 1.0% | -1.9% | 9.4% |
| Nettoergebnis | $732.0K | $-118M | $-30M | $-74M | $103M |
| Verwässerte EPS | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.6 | 0.8 | 0.8 | 0.8 | · |
| Liquiditätsgrad | 2.4 | 2.6 | 2.5 | 2.5 | 5.1 |
| Quick Ratio | 0.4 | 0.9 | 0.9 | 0.9 | 3.3 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $92M | $125M | $82M | $-152M | $199M |
Institutionelle Eigentümer (13F) 305 Einreicher · $4.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
305
Gehaltener Wert
$4.1B
Neue Positionen
43
Geschlossene Positionen
30
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 43 (-6 vs. Vorquartal) | 30 (-15 vs. Vorquartal) | 118 (+28 vs. Vorquartal) | 82 (-14 vs. Vorquartal) | -1.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $550.249.759 | 3.753.409 | 13,48% | Aktien |
| VANGUARD GROUP INC | $387.312.811 | 2.714.746 | 9,49% | Aktien |
| JANUS HENDERSON GROUP PLC | $345.607.263 | 2.676.012 | 8,47% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $215.587.468 | 1.470.583 | 5,28% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $190.305.412 | 1.298.127 | 4,66% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $164.666.544 | 1.123.237 | 4,03% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $154.443.449 | 1.053.476 | 3,78% | Aktien |
| STATE STREET CORP | $150.177.172 | 1.024.369 | 3,68% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $109.340.684 | 739.138 | 2,68% | Aktien |
| AMERIPRISE FINANCIAL INC | $101.091.847 | 689.573 | 2,48% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $96.836.293 | 660.423 | 2,37% | Aktien |
| River Road Asset Management, LLC | $91.814.114 | 626.290 | 2,25% | Aktien |
| CITADEL ADVISORS LLC | $78.610.585 | 536.225 | 1,93% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $66.157.502 | 451.279 | 1,62% | Aktien |
| JPMORGAN CHASE & CO | $65.312.452 | 440.468 | 1,60% | Aktien |
| GOLDMAN SACHS GROUP INC | $61.182.264 | 417.342 | 1,50% | Aktien |
| MORGAN STANLEY | $54.620.878 | 372.583 | 1,34% | Aktien |
| BANK OF AMERICA CORP /DE/ | $54.059.336 | 368.754 | 1,32% | Aktien |
| TORONTO DOMINION BANK | $52.486.172 | 358.023 | 1,29% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $48.532.223 | 331.052 | 1,19% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $48.227.000 | 328.969 | 1,18% | Aktien |
| REINHART PARTNERS, LLC. | $46.147.615 | 314.768 | 1,13% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $43.614.563 | 297.505 | 1,07% | Aktien |
| NORTHERN TRUST CORP | $43.361.202 | 295.779 | 1,06% | Aktien |
| FMR LLC | $41.516.428 | 283.195 | 1,02% | Aktien |
| FEDERATED HERMES, INC. | $35.688.010 | 243.438 | 0,87% | Aktien |
| BROWN ADVISORY INC | $34.772.232 | 237.191 | 0,85% | Aktien |
| OBERWEIS ASSET MANAGEMENT INC/ | $34.751.530 | 237.050 | 0,85% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $32.552.823 | 222.052 | 0,80% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $31.094.299 | 212.103 | 0,76% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $29.850.399 | 203.618 | 0,73% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $28.651.797 | 195.442 | 0,70% | Aktien |
| Bank of New York Mellon Corp | $26.966.404 | 183.945 | 0,66% | Aktien |
| NORGES BANK | $26.055.658 | 177.733 | 0,64% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $25.241.735 | 172.181 | 0,62% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $24.343.810 | 166.056 | 0,60% | Aktien |
| Point72 Asset Management, L.P. | $24.257.755 | 165.469 | 0,59% | Aktien |
| Woodline Partners LP | $24.087.113 | 164.305 | 0,59% | Aktien |
| Quantinno Capital Management LP | $23.256.917 | 158.642 | 0,57% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $21.841.347 | 148.986 | 0,54% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $21.327.368 | 145.480 | 0,52% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $18.959.631 | 129.329 | 0,46% | Aktien |
| Defilade Capital Management, L.P. | $15.495.620 | 105.700 | 0,38% | Aktien |
| UBS Group AG | $14.515.160 | 99.012 | 0,36% | Aktien |
| Nuveen, LLC | $14.023.903 | 95.661 | 0,34% | Aktien |
| Invesco Ltd. | $13.846.957 | 94.454 | 0,34% | Aktien |
| GLENMEDE TRUST CO NA | $13.638.051 | 93.029 | 0,33% | Aktien |
| Public Sector Pension Investment Board | $12.585.170 | 85.847 | 0,31% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $10.257.222 | 79.421 | 0,25% | Aktien |
| RHUMBLINE ADVISERS | $9.138.587 | 62.337 | 0,22% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Smiths Group plc, Smiths Group International Holdings Limited ×3 Einreichungen | 18. Juli 2024 | · | Erste Einreichung | · | SEC |
| Pfizer Inc. (“Pfizer”) IRS Identification Nos. of above persons (entities only), C. P. Pharmaceuticals International C.V. (the “Shareholder”) IRS Identification Nos. of above persons (entities only), PFIZER PRODUCTION LLC (“PPL”) IRS Identification Nos. of above persons (entities only), PFIZER MANUFACTURING LLC (“PML” and together with PPL, the “General Partners”) IRS Identification Nos. of above persons (entities only) ×2 Einreichungen | 16. November 2018 | · | Erste Einreichung | · | SEC |
| Pfizer Inc. ("Pfizer") IRS Identification Nos. of above persons (entities only), C. P. Pharmaceuticals International C.V. IRS Identification Nos. of above persons (entities only), PFIZER PRODUCTION LLC IRS Identification Nos. of above persons (entities only), PFIZER MANUFACTURING LLC IRS Identification Nos. of above persons (entities only) | 13. Februar 2017 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter | 12. November 2002 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 28 Insider · 12 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Vivek Jain | Chairman and CEO | 15. März 2026 M | 126.833 | 0 | 0 | $0 |
| Brian Michael Bonnell | Chief Financial Officer | 1. September 2026 S | 56.062 | 0 | 5 | $-2.724.787 |
| Francis J Obrien | Chief Financial Officer | 15. Februar 2008 P | 8.046 | 0 | 0 | $0 |
| Christian B. Voigtlander | Chief Operating Officer | 11. August 2026 S | 37.377 | 0 | 1 | $-1.633.382 |
| Virginia Ruth Sanzone | VP, General Counsel | 3. September 2026 S | 14.604 | 0 | 6 | $-1.255.170 |
| Daniel Woolson | VP, GM-Infusion Capital | 13. August 2026 S | 17.062 | 0 | 3 | $-1.704.305 |
| Ben Sousa | Chief Information Officer | 12. August 2026 S | 3.076 | 0 | 1 | $-401.220 |
| Kevin J Mcgrody | Chief Accounting Officer | 6. März 2022 M | 4.846 | 0 | 0 | $0 |
| Thomas D Mccall | Vice President and Gen'l Mgr. | 17. Januar 2020 M | 7.841 | 0 | 0 | $0 |
| Burcar Alison Brummett | Vice President and Gen'l Mgr. | 27. März 2019 M | 6.794 | 0 | 0 | $0 |
| Steven Riggs | VP Operations | 11. Februar 2018 M | 3.127 | 0 | 0 | $0 |
| Richard A Costello | Vice President Sales | 25. Februar 2014 X | 285 | 0 | 0 | $0 |
| Laurie Hernandez | Direktor | 13. Mai 2026 A | 4.862 | 0 | 0 | $0 |
| David C. Greenberg | Direktor | 13. Mai 2026 A | 9.214 | 0 | 1 | $-297.934 |
| Donald Abbey | Direktor | 13. Mai 2026 A | 6.004 | 0 | 0 | $0 |
| Kolleen T Kennedy | Direktor | 13. Mai 2026 A | 4.539 | 0 | 0 | $0 |
| George A Lopez | Direktor | 14. März 2024 S | 877.343 | 0 | 0 | $0 |
| Robert S Swinney | Direktor | 15. September 2021 S | 20.816 | 0 | 0 | $0 |
| Joseph R Saucedo | Direktor | 14. Mai 2018 S | 0 | 0 | 0 | $0 |
| Richard Sherman MD | Direktor | 16. Mai 2017 M | 69.942 | 0 | 0 | $0 |
| Jack Brown | Direktor | 5. Oktober 2015 X | 19.862 | 0 | 0 | $0 |
| John J Connors | Direktor | 9. Juni 2015 M | 2.456 | 0 | 0 | $0 |
| Michael T Kovalchik | Direktor | 9. Mai 2014 M | 4.602 | 0 | 0 | $0 |
| Elisha W Finney | · | 11. August 2026 S | 4.871 | 0 | 2 | $-249.417 |
| David F Hoffmeister | · | 13. Mai 2026 A | 6.004 | 0 | 0 | $0 |
| Smiths Group International Holdings Ltd | · | 29. Februar 2024 S | 1.670.000 | 0 | 0 | $0 |
| SMITHS GROUP PLC | · | 29. Februar 2024 S | 1.670.000 | 0 | 0 | $0 |
| Scott E Lamb | · | 14. Februar 2020 M | 16.274 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 52 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PSCH · Invesco Exchange-Traded Fund Trust … | 2,15% | 23.775 SH | 2. Oktober 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,47% | 690 SH | 2. Oktober 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,27% | 4.061 SH | 2. Oktober 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,24% | 8.560 NS | 31. Juli 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,24% | 116.117 NS | 31. Juli 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,23% | 21.594 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,21% | 35.586 SH | 2. Oktober 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,20% | 87.418 SH | 19. August 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,20% | 27.578 SH | 19. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,19% | 14.279 SH | 19. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 6.091 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,15% | 11.901 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,14% | 734 NS | 31. Juli 2026 | N-PORT |
| FYT · First Trust Exchange-Traded AlphaDE… | 0,14% | 1.600 NS | 31. Juli 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,14% | 17.020 SH | 2. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,13% | 11.831 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,13% | 632.805 SH | 11. September 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 142.142 SH | 19. August 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,10% | 85.853 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,09% | 77.820 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,08% | 364.019 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,07% | 11.599 SH | 11. September 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 11.256 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,05% | 71.375 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,05% | 2.813 SH | 11. September 2026 | Täglich |
| SMDX · Tidal Trust III | 0,04% | 311 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 286.547 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,04% | 573.524 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,03% | 1.443 SH | 11. September 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,03% | 1.111 NS | 31. Juli 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,03% | 278 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 58.989 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2.490 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,02% | 3.385 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,02% | 15.263 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 1.530 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 792.153 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 5.438 SH | 19. August 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,01% | 6.148 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 7.354 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,01% | 32.068 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 6.145 SH | 11. September 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 19.221 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.073 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 1.525.334 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 113.714 SH | 9. September 2026 | Täglich |
| IJS · iShares Trust | · | 115.864 SH | 8. September 2026 | Täglich |
| IWN · iShares Trust | · | 232.180 SH | 11. September 2026 | Täglich |
| XJR · iShares Trust | · | 3.458 SH | 31. August 2026 | Täglich |
| SVAL · iShares Trust | · | 5.101 SH | 3. September 2026 | Täglich |
| ISCB · iShares Trust | · | 1.008 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 3.047 SH | 11. September 2026 | Täglich |
ICUI Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$192.50
+20,8%
5 38,5%
Starker Kauf
7 53,8%
Kauf
1 7,7%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
8 Analysten · 2026-10-01Mittelwert-Ziel $193.38 +21,3%
← Unter allen Zielen
Aktueller Preis $159.38
Tief$178.00
Mittelwert$193.38
Hoch$210.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | · |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
| STAA | $1.17B | -14.6 | -23.7% | -33.6% | -23.6% | 76.2% |
| BVS | · | 22.5 | -0.91% | 4.0% | 13.7% | 68.3% |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026